StockData
Jade Biosciences, Inc. logo

Jade Biosciences, Inc. (JBIO) stock

JBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$15.40+0.06 (+0.42%)

Close on Nov 17, 2026Market cap $979.40MP/E –Yield –

Jade Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Jade Biosciences's price to book ratio was 2.4× on Nov 11, 2026, against 2.3× a year earlier. Over the last 4 years it ranged from 1.3× to 262.5×, with a median of 72.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.4×−0.4
2025Dec 31, 20252.8×−16.7
2024Jul 31, 202419.6×−154.7
2023Dec 29, 2023174.2×−6.4
2022Dec 30, 2022180.6×+124.6
2021Dec 31, 202156.0×–

More Jade Biosciences figures

See a number that looks wrong?